Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBVX.L Share News (BVX)

  • There is currently no data for BVX

BVX.L News

AIM WINNERS & LOSERS: Bivictrix surges on lead for BVX001 programme
7 Dec 2022

AIM WINNERS & LOSERS: Bivictrix surges on lead for BVX001 programme

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Bivictrix identifies lead for antibody drug conjugates programme
7 Dec 2022

Bivictrix identifies lead for antibody drug conjugates programme

(Alliance News) - Bivictrix Therapeutics PLC on Wednesday said it identified a development lead for its BVX001 programme, which aims to formulate the ...

BiVictriX Therapeutics reports widening loss following R&D investment
12 Sep 2022

BiVictriX Therapeutics reports widening loss following R&D investment

(Alliance News) - BiVictriX Therapeutics PLC on Monday reported a widening loss in the first half of 2022, as a result of higher research cosrs.

TRADING UPDATES: Byotrol anticipating positive full-year earnings
11 Jul 2022

TRADING UPDATES: Byotrol anticipating positive full-year earnings

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

BiVictriX upbeat on recent pipeline progress
11 Jul 2022

BiVictriX upbeat on recent pipeline progress

(Sharecast News) - Biotechnology company BiVictriX Therapeutics updated the market on its pipeline on Monday, reporting "significant progress" with it...

TRADING UPDATES: BiVictriX expands development; Okyo wins US patent
23 Feb 2022

TRADING UPDATES: BiVictriX expands development; Okyo wins US patent

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

BiVictriX adds two new drug development programmes
23 Feb 2022

BiVictriX adds two new drug development programmes

(Sharecast News) - Biotechnology company BiVictriX Therapeutics announced the expansion of its therapeutic pipeline on Wednesday, with two additional ...